Quick Answer
Verrica Pharmaceuticals Inc. reported Common Stock Shares Outstanding of 17.18 million shares for the year ending 2025.
- Verrica Pharmaceuticals Inc. showed an increase of +87.2% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Verrica Pharmaceuticals Inc.'s annual report (Form 10-K), filed with the SEC on March 11, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2018: 25.70 million shares | Q3 2018: 25.70 million shares | Q1 2019: 25.71 million shares | Q2 2019: 25.74 million shares | Q3 2019: 25.74 million shares | Q1 2020: 25.81 million shares | Q2 2020: 25.81 million shares | Q3 2020: 25.87 million shares | Q1 2021: 27.49 million shares | Q2 2021: 27.51 million shares | Q3 2021: 27.52 million shares | Q1 2022: 27.62 million shares | Q2 2022: 27.62 million shares | Q3 2022: 41.09 million shares | Q1 2023: 41.85 million shares | Q2 2023: 41.85 million shares | Q3 2023: 42.06 million shares | Q1 2024: 42.42 million shares | Q2 2024: 42.46 million shares | Q3 2024: 45.60 million shares | Q1 2025: 91.79 million shares | Q2 2025: 9.25 million shares | Q3 2025: 9.49 million shares.
- Over the full 9 years of available data (2017 to 2025), Verrica Pharmaceuticals Inc.'s Common Stock Shares Outstanding has grown by 364.4%.
- Historical annual values: Fiscal year 2025: 17.18 million shares | Fiscal year 2024: 9.18 million shares | Fiscal year 2023: 42.41 million shares | Fiscal year 2022: 41.09 million shares | Fiscal year 2021: 27.52 million shares | Fiscal year 2020: 25.44 million shares | Fiscal year 2019: 25.79 million shares | Fiscal year 2018: 25.70 million shares | Fiscal year 2017: 3.70 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: